Biotech Series B Investors & VC Firms
900 firms in this list, with a median first check of $550K. 188 of them lead rounds. Generated from verified public data and updated continuously.
UKSE
SheffieldSeries A–Late Stage$31.8K – $1.3M
34 people
MPM Capital
Pre-Seed–Late Stage
27 people
ACT Venture Capital
DublinSeed–Growth$1.1M – $16.2M
10 people
WI Harper Group
San FranciscoSeed–Series C$5M – $15M
25 people
Pan-Lin Capital
ShanghaiPre-Seed–Growth
5 people
SPRINGROCK VENTURES
SeattleSeed–Late Stage$2M – $5M
14 people
K3 Ventures
SingaporeSeed–Growth$1.2M – $42M
23 people
Lumira Ventures
TorontoPre-Seed–Late Stage$1M – $10M
17 people
JDRF T1D Fund
BostonSeed–Late Stage
28 people
Peregrine Ventures
Or YehudaSeed–Late Stage$500K – $3M
14 people
Visionaries Club
BerlinPre-Seed–Late Stage$900K
16 people
Oregon Venture Fund
PortlandPre-Seed–Growth$500K – $5M
9 people
Panacea Venture
SingaporePre-Seed–Late Stage
20 people
Calculus Capital Ltd.
LondonSeed–Late Stage$2.5M
24 people
Mitsui Global Investment
Menlo ParkPre-Seed–Late Stage$500K – $10M
14 people
Tesi (Finnish Industry Investment Ltd)
HelsinkiPre-Seed–Late Stage$5.4M – $16.2M
11 people
Bay City Capital
San RafaelSeed–Late Stage$5M – $10M
8 people
Beyond Ventures
Hong KongSeed–Growth$720K – $138M
16 people
SucSEED Indovation
HyderabadPre-Seed–Growth$4K – $1.1M
11 people
UpHonest Capital
Silicon ValleyPre-Seed–Series B$50K – $1M
20 people
Bootstrap Europe
LondonSeries A–Late Stage
19 people
Angel Bridge Co.,Ltd.
TokyoPre-Seed–Growth$792K – $62M
9 people
K2 HealthVentures
BostonSeries A–Late Stage$10M – $100M
22 people
DAYLI Partners
SeoulSeed–Late Stage
Related lists
Series B Investors & VC Firms (4094)Biotech Investors & VC Firms (2107)Biotech Seed Investors & VC Firms (1754)Series B Investors & VC Firms in United States (1625)Biotech Series A Investors & VC Firms (1596)SaaS Series B Investors & VC Firms (1317)Series B Investors & VC Firms in Global (1265)Enterprise Software Series B Investors & VC Firms (1242)Healthtech Series B Investors & VC Firms (1216)Fintech Series B Investors & VC Firms (1141)
Data sourced from public filings and firms' own websites — see our methodology.





















.jpg)


















































